Credit Suisse’s Chemed CHE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $16.7M | Buy |
26,057
+373
| +1% | +$227K | 0.02% | 693 |
|
|
2023
Q4 | $15M | Buy |
25,684
+2,325
| +10% | +$1.3M | 0.01% | 751 |
|
|
2023
Q3 | $12.1M | Sell |
23,359
-211
| -0.9% | -$110K | 0.01% | 822 |
|
|
2023
Q2 | $12.8M | Buy |
23,570
+4,159
| +21% | +$2.27M | 0.01% | 820 |
|
|
2023
Q1 | $10.4M | Buy |
19,411
+804
| +4% | +$410K | 0.01% | 920 |
|
|
2022
Q4 | $9.5M | Buy |
18,607
+4,112
| +28% | +$2M | 0.01% | 958 |
|
|
2022
Q3 | $6.33M | Buy |
14,495
+1,444
| +11% | +$694K | 0.01% | 1128 |
|
|
2022
Q2 | $6.13M | Sell |
13,051
-788
| -6% | -$384K | 0.01% | 1165 |
|
|
2022
Q1 | $7.01M | Sell |
13,839
-197
| -1% | -$94.5K | 0.01% | 1239 |
|
|
2021
Q4 | $7.43M | Sell |
14,036
-2,901
| -17% | -$1.39M | ﹤0.01% | 1724 |
|
|
2021
Q3 | $7.88M | Sell |
16,937
-65
| -0.4% | -$30.6K | ﹤0.01% | 1707 |
|
|
2021
Q2 | $8.23M | Sell |
17,002
-2,161
| -11% | -$1.04M | ﹤0.01% | 1702 |
|
|
2021
Q1 | $8.81M | Buy |
19,163
+2,577
| +16% | +$1.26M | ﹤0.01% | 1664 |
|
|
2020
Q4 | $8.83M | Sell |
16,586
-116
| -0.7% | -$57K | ﹤0.01% | 1666 |
|
|
2020
Q3 | $8.02M | Buy |
16,702
+234
| +1% | +$115K | ﹤0.01% | 1497 |
|
|
2020
Q2 | $7.43M | Sell |
16,468
-2,622
| -14% | -$1.17M | 0.01% | 1457 |
|
|
2020
Q1 | $8.27M | Sell |
19,090
-8,156
| -30% | -$3.64M | 0.01% | 1266 |
|
|
2019
Q4 | $12M | Sell |
27,246
-861
| -3% | -$362K | 0.01% | 1309 |
|
|
2019
Q3 | $11.7M | Sell |
28,107
-1,142
| -4% | -$466K | 0.01% | 1218 |
|
|
2019
Q2 | $10.6M | Sell |
29,249
-2,677
| -8% | -$895K | 0.01% | 1284 |
|
|
2019
Q1 | $10.2M | Buy |
31,926
+17,297
| +118% | +$5.31M | 0.01% | 1232 |
|
|
2018
Q4 | $4.14M | Sell |
14,629
-17,812
| -55% | -$5.38M | ﹤0.01% | 1712 |
|
|
2018
Q3 | $10.4M | Buy |
32,441
+4,724
| +17% | +$1.51M | 0.01% | 1229 |
|
|
2018
Q2 | $8.92M | Buy |
27,717
+8,848
| +47% | +$2.77M | 0.01% | 1302 |
|
|
2018
Q1 | $5.15M | Sell |
18,869
-4,775
| -20% | -$1.26M | ﹤0.01% | 1688 |
|
|
2017
Q4 | $5.75M | Sell |
23,644
-10,466
| -31% | -$2.38M | 0.01% | 1676 |
|
|
2017
Q3 | $6.89M | Buy |
34,110
+18,230
| +115% | +$3.58M | 0.01% | 1507 |
|
|
2017
Q2 | $3.25M | Sell |
15,880
-4,032
| -20% | -$803K | ﹤0.01% | 1894 |
|
|
2017
Q1 | $3.64M | Sell |
19,912
-2,417
| -11% | -$421K | ﹤0.01% | 1877 |
|
|
2016
Q4 | $3.58M | Buy |
22,329
+9,799
| +78% | +$1.44M | ﹤0.01% | 1919 |
|
|
2016
Q3 | $1.77M | Sell |
12,530
-4,562
| -27% | -$635K | ﹤0.01% | 2468 |
|
|
2016
Q2 | $2.33M | Buy |
17,092
+6,658
| +64% | +$883K | ﹤0.01% | 2222 |
|
|
2016
Q1 | $1.41M | Sell |
10,434
-9,339
| -47% | -$1.26M | ﹤0.01% | 2461 |
|
|
2015
Q4 | $2.96M | Sell |
19,773
-11,307
| -36% | -$1.67M | ﹤0.01% | 1998 |
|
|
2015
Q3 | $4.15M | Buy |
31,080
+3,501
| +13% | +$490K | 0.01% | 1688 |
|
|
2015
Q2 | $3.62M | Buy |
27,579
+14,971
| +119% | +$1.85M | ﹤0.01% | 2032 |
|
|
2015
Q1 | $1.5M | Sell |
12,608
-15,771
| -56% | -$1.75M | ﹤0.01% | 2638 |
|
|
2014
Q4 | $3M | Buy |
28,379
+5,891
| +26% | +$622K | ﹤0.01% | 2190 |
|
|
2014
Q3 | $2.31M | Sell |
22,488
-123
| -0.5% | -$12.5K | ﹤0.01% | 2375 |
|
|
2014
Q2 | $2.12M | Sell |
22,611
-3,863
| -15% | -$343K | ﹤0.01% | 2661 |
|
|
2014
Q1 | $2.37M | Buy |
26,474
+10,556
| +66% | +$860K | ﹤0.01% | 2390 |
|
|
2013
Q4 | $1.22M | Sell |
15,918
-13,233
| -45% | -$976K | ﹤0.01% | 3104 |
|
|
2013
Q3 | $2.08M | Buy |
29,151
+22,151
| +316% | +$1.58M | ﹤0.01% | 2359 |
|
|
2013
Q2 | $507K | Buy |
+7,000
| New | +$513K | ﹤0.01% | 3297 |
|
Other funds holding CHE
DCP
Credit Suisse's CHE Position: Q1 2024 in Review
Credit Suisse increased its Chemed (CHE) stake by 1.5% in Q1 2024, buying an estimated $227K and bringing the position to 26,057 shares worth $16.7M. The position accounts for 0.02% of the portfolio, ranked #693.
Credit Suisse first reported a position in CHE in Q2 2013 and has held it in 44 quarters since. 510 funds tracked by Wall St. Rank hold CHE as of Q1 2024.
- Credit Suisse held 26,057 shares of Chemed worth $16.7M as of Q1 2024.
- Credit Suisse bought 373 Chemed shares in Q1 2024, an estimated $227K.
- Chemed made up 0.02% of Credit Suisse's portfolio in Q1 2024, its #693 holding.
- Credit Suisse first reported a position in Chemed in Q2 2013 and has held it in 44 quarters since.
- 510 funds tracked by Wall St. Rank held Chemed as of Q1 2024.
Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.